We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+8.66%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$19.6B
AUM Growth
+$2.1B
Cap. Flow
+$943M
Cap. Flow %
4.81%
Top 10 Hldgs %
14.75%
Holding
739
New
183
Increased
150
Reduced
140
Closed
230

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$263M
2
TEL icon
TE Connectivity
TEL
+$242M
3
ZM icon
Zoom
ZM
+$242M
4
QCOM icon
Qualcomm
QCOM
+$208M
5
META icon
Meta Platforms (Facebook)
META
+$190M

Sector Composition

Rank Sector Weight
1 Technology 23.88%
2 Consumer Discretionary 18.76%
3 Healthcare 12.63%
4 Industrials 12.54%
5 Financials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BANC icon
476
Banc of California
BANC
$3.09B
$678K ﹤0.01%
+46,033
New +$639K
KPRX icon
477
Kiora Pharmaceuticals
KPRX
$11.5M
$662K ﹤0.01%
180,780
GEHC icon
478
GE HealthCare
GEHC
$32.9B
$660K ﹤0.01%
+7,031
New +$590K
BLDR icon
479
Builders FirstSource
BLDR
$8.04B
$635K ﹤0.01%
3,274
-3,005
-48% -$498K
EOSE icon
480
Eos Energy Enterprises
EOSE
$1.53B
$594K ﹤0.01%
+200,000
New +$423K
EA
481
DELISTED
Electronic Arts
EA
$573K ﹤0.01%
+3,993
New +$579K
ANRO icon
482
Alto Neuroscience
ANRO
$1.11B
$572K ﹤0.01%
50,000
CTKB icon
483
Cytek Biosciences
CTKB
$614M
$554K ﹤0.01%
100,000
KOPN icon
484
Kopin
KOPN
$941M
$511K ﹤0.01%
+700,000
New +$642K
HOWL icon
485
Werewolf Therapeutics
HOWL
$18.6M
$500K ﹤0.01%
235,705
VEEV icon
486
Veeva Systems
VEEV
$38.6B
$497K ﹤0.01%
2,369
-319,446
-99% -$63.1M
JWN
487
DELISTED
Nordstrom
JWN
$479K ﹤0.01%
+21,318
New +$474K
BLRX
488
BioLineRX
BLRX
$12.4M
$465K ﹤0.01%
21,662
-27,172
-56% -$746K
LGCY
489
Legacy Education Inc
LGCY
$136M
$428K ﹤0.01%
+93,000
New +$403K
ANET icon
490
Arista Networks
ANET
$248B
$408K ﹤0.01%
+4,256
New +$371K
HYPR icon
491
Hyperfine
HYPR
$100M
$405K ﹤0.01%
375,000
GUTS icon
492
Fractyl Health
GUTS
$109M
$380K ﹤0.01%
150,000
DFTX
493
Definium Therapeutics
DFTX
$5.43B
$379K ﹤0.01%
+66,694
New +$464K
INBS icon
494
Intelligent Bio Solutions
INBS
$4.88M
$357K ﹤0.01%
+20,620
New +$321K
GPCR icon
495
Structure Therapeutics
GPCR
$3.71B
$336K ﹤0.01%
7,660
-699,730
-99% -$27.1M
OTLY
496
Oatly Group
OTLY
$413M
$316K ﹤0.01%
18,484
Z icon
497
Zillow
Z
$7.7B
$292K ﹤0.01%
+4,578
New +$246K
PDD icon
498
Pinduoduo
PDD
$129B
$268K ﹤0.01%
+1,987
New +$244K
JEF icon
499
Jefferies Financial Group
JEF
$12.7B
$264K ﹤0.01%
4,293
-1,297,600
-100% -$73.6M
SRZN icon
500
Surrozen
SRZN
$292M
$244K ﹤0.01%
20,376

Similar funds

Alyeska Investment Group's Q3 2024 Portfolio in Review

As of Q3 2024, Alyeska Investment Group held 739 positions worth $19.6B, up 12% from $17.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group deployed $943M of net new capital in Q3 2024, opening 183 new positions and adding to 150 existing holdings. Its largest new stake was Microsoft: 734,107 shares worth $316M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Zoom, an estimated $242M trimmed.

  • Alyeska Investment Group's largest Q3 2024 buy was Microsoft: 734,107 shares worth $316M.
  • Alyeska Investment Group added most to lululemon athletica in Q3 2024, an estimated $221M increase.
  • Alyeska Investment Group's biggest Q3 2024 reduction was Zoom, cutting an estimated $242M.
  • Alyeska Investment Group fully exited Apple in Q3 2024, selling an estimated $263M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $19.6B portfolio in Q3 2024.
  • Alyeska Investment Group opened 183 new positions and closed 230 in Q3 2024.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $19.6B.

Based on Alyeska Investment Group's 13F filing for Q3 2024, filed 14 Nov 2024.